CCR4 dependent migration of Foxp3 + T reg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200 tg recipients

Immunology Letters

Volumn 141, Issue 1, 2011, Pages 116-122

  Yu, Kai ^a   Chen, Zhiqi ^a   Khatri, Ismat ^a   Gorczynski, Reginald M ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

CCL17 19; CCR4; CD200 transgene; Foxp3+Treg; ShRNA

Indexed keywords

CD134 ANTIGEN; CD137 LIGAND; CD200 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GENE PRODUCT; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GRANZYME B; ICOS PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; JANUS KINASE 1; LENTIVIRUS VECTOR; LIGHT PROTEIN; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN FOS; PROTEIN JUN; SHORT HAIRPIN RNA; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CHEMOKINE RECEPTOR CCR4 GENE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 GENE; FOXP3 GENE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR GENE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SKIN GRAFT; UPREGULATION;

ANIMALS; ANTIGENS, CD; CHEMOKINE CCL17; CHEMOKINE CCL22; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; GRAFT SURVIVAL; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LYMPH NODES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROARRAY ANALYSIS; RECEPTORS, CCR4; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 80955142607     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.09.002     Document Type: Article

References (28)

1. Sakaguchi S. Naturally arising Foxp3-expressing CD25(+) CD4(+) regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
2. Chen W.J., Jin W.W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4(+)CD25(-) naive T cells to CD4(+)CD25(+) regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
3. Petroff M.G., Chen L., Phillips T.A., Hunt J.S. B7 family molecules: Novel immunomodulators at the maternal-fetal interface. Placenta 2002, 23:S95-S101.
4. Tsushima F., Iwai H., Otsuki N., Abe M., Hirose S., Yamazaki T., et al. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur J Immunol 2003, 33:2773-2782.
5. Bluestone J.A., StClair E.W., Turka L.A. CTLA41g. Bridging the basic immunology with clinical application. Immunity 2006, 24:233-238.
6. Afaneh C., Muthukumar T., Lubetzky M., Ding R.C., Snopkowski C., Sharma V.K., et al. Urinary Cell Levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation 2010, 90:1381-1387.
7. Gorczynski R.M., Chen Z.Q., He W., Khatri I., Sun Y., Yu K., et al. Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. J Immunol 2009, 183:1560-1568.
8. Gorczynski RM, Chen Z, Khatri I, Yu K. Graft-infiltrating cells expressing a CD200 transgene prolong allogeneic skin graft survival in association with local increases in Foxp3+Treg and mast cells. Transpl Immunol, 25; in press.
9. Lee I., Wang L.Q., Wells A.D., Dorf M.E., Ozkaynak E., Hancock W.W. Recruitment of Foxp3(+) T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005, 201:1037-1044.
10. Yuan Q., Bromley S.K., Means T.K., Jones K.J., Hatashi F., Bhan A.K., et al. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J Exp Med 2007, 204:1327-1334.
11. Kai G., Chen Z., Yang S., Gorczynski R.M. Decreased alloreactivity using donor cells from mice expressing a CD200 transgene under control of a tetracycline-inducible promoter. Transplantation 2005, 80:394-401.
12. Qu Y., Zhang B., Zhao L., Liu G.W., Ma H.X., Rao E.Y., et al. The effect of immunosuppressive drug rapamycin on regulatory CD4+ CD25+ Foxp3+ T cells in mice. Transpl Immunol 2007, 17:153-161.
13. Dijke I.E., Weimar W., Baan C.C. Regulatory T cells after organ transplantation: where does their action take place?. Hum Immunol 2008, 69:389-398.
14. DeGennaro L.A., Popi A.F., deAlmeida S.R., Lopes J.D., Mariano M. B-1 cells modulate oral tolerance in mice. Immunol Lett 2009, 124:63-69.
15. Brouard S., Mansfield E., Braud C., Li L., Giral M., Hsieh S.C., et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 2007, 104:15448-15453.
16. Bradley S.P., Banner B., Elias G., Pahari M.P., Brown M.A., Rastellani C., et al. Genetic expression profile during acute cellular rejection in clinical intestinal transplantation. Transplantation 2008, 86:998-1001.
17. Cobbold S.P. The hidden truth about gene expression in Tregs: is it what you don't see that counts?. Eur J Immunol 2006, 36:1360-1363.
18. Scheibner K.A., Lutz M.A., Boodoo S., Fenton M.J., Powell J.D., Horton M.R. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006, 177:1272-1281.
19. Fontenot J.D., Rudensky A.Y. Molecular aspects of regulatory T cell development. Semin Immunol 2004, 16:73-80.
20. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
21. Ammirati E., Cianflone D., Banfi M., Vecchio V., Palini A., DeMetrio M., et al. Circulating CD4(+) CD25(Hi)CD127(Lo) regulatory t-cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2010, 30:1832-2359.
22. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000, 192:295-302.
23. O'Garra A., Vieira P.L., Vieira P., Goldfeld A.E. IL-10-producing and naturally occurring CD4(+) Tregs: limiting collateral damage. J Clin Invest 2004, 114:1372-1378.
24. Nakamura K., Kitani A., Fuss I., Pedersen A., Harada N., Nawata H., et al. TGF-beta 1 plays an important role in the mechanism of CD4(+)CD25(+) regulatory T cell activity in both humans and mice. J Immunol 2004, 172:834-842.
25. Gondek D.C., Lu L.F., Quezada S.A., Sakaguchi S., Noelle R.J. Cutting edge: contact-mediated suppression by CD4(+)-CD25(+) regulatory cells involves a granzyme B-dependent, perforin- independent mechanism. J Immunol 2005, 174:1783-1786.
26. Pandiyan P., Zhang L., Ishihara S., Reed J., Lenardo M.J. CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 2007, 8:1353-1362.
27. Jonuleit H., Adema G., Schmitt E. Immune regulation by regulatory T cells: implications for transplantation. Transpl Immunol 2003, 11:267-276.
28. Terada N., Nomura T., Kim W.J., Otsuka Y., Takahashi R., Kishi H. Expression of C-C chemokine TARC in human nasal mucosa and its regulation by cytokines. Clin Exp Allergy 2001, 31:1923-1931.